Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Surgery (London, England)
|
December 5, 2023
Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study)
Yingnan Yang, Jinfeng Zhang, Hongxue Meng, et al.
Frontiers in Physiology
|
May 22, 2018
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
Yang Liu, Ye Jin, Jun Li, et al.
Journal of Thoracic Disease
|
July 10, 2019
The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer
Xiaoyuan Wang, Hang Yin, Luquan Zhang, et al.
Cancer Immunology, Immunotherapy : CII
|
December 30, 2022
Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment
Xiaoyuan Wang, Xiaodong Ling, Changhong Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 19, 2017
Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells
Lei Zhao, Jun Li, Yang Liu, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Programmable conjugative CRISPR interference targeting genotoxin in the gut
Brian Hamp, Hania Timek, Chengyuan Fang, et al.
Research Square
|
November 24, 2025
Programmable conjugative CRISPR interference targeting genotoxin in the gut
Brian Hamp, Hania Timek, Chengyuan Fang, et al.
BMC Medicine
|
December 28, 2025
Preoperative conversion therapy of camrelizumab combined with paclitaxel and nedaplatin for unresectable advanced esophageal squamous cell carcinoma: a phase 2 study
Jinhong Zhu, Jinfeng Zhang, Xiaodong Ling, et al.
Nature Microbiology
|
December 23, 2025
Publisher Correction: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
Shaobo Yang, Zongqi Wang, Chengyuan Fang, et al.
Nature Microbiology
|
December 8, 2025
Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
Shaobo Yang, Zongqi Wang, Chengyuan Fang, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
International Journal of Surgery (London, England)
|
December 5, 2023
Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study)
Yingnan Yang, Jinfeng Zhang, Hongxue Meng, et al.
Frontiers in Physiology
|
May 22, 2018
Small Bowel Transit and Altered Gut Microbiota in Patients With Liver Cirrhosis
Yang Liu, Ye Jin, Jun Li, et al.
Journal of Thoracic Disease
|
July 10, 2019
The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer
Xiaoyuan Wang, Hang Yin, Luquan Zhang, et al.
Cancer Immunology, Immunotherapy : CII
|
December 30, 2022
Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment
Xiaoyuan Wang, Xiaodong Ling, Changhong Wang, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 19, 2017
Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells
Lei Zhao, Jun Li, Yang Liu, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Programmable conjugative CRISPR interference targeting genotoxin in the gut
Brian Hamp, Hania Timek, Chengyuan Fang, et al.
Research Square
|
November 24, 2025
Programmable conjugative CRISPR interference targeting genotoxin in the gut
Brian Hamp, Hania Timek, Chengyuan Fang, et al.
BMC Medicine
|
December 28, 2025
Preoperative conversion therapy of camrelizumab combined with paclitaxel and nedaplatin for unresectable advanced esophageal squamous cell carcinoma: a phase 2 study
Jinhong Zhu, Jinfeng Zhang, Xiaodong Ling, et al.
Nature Microbiology
|
December 23, 2025
Publisher Correction: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
Shaobo Yang, Zongqi Wang, Chengyuan Fang, et al.
Nature Microbiology
|
December 8, 2025
Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut
Shaobo Yang, Zongqi Wang, Chengyuan Fang, et al.
Page
of 2